Gastroenterology

It's a constant question of whether physician decision making has benefitted the patients or not.

The molecular test PancraGen helps identify false negative cases that could be missed by first-line tests like imaging, cytology and fluid chemistry.

In the world of gastrointestinal conditions clostridium difficile, or c-diff is becoming a more common condition confronting doctors. Finding the best treatment method remains to be seen.

Among men who have sex with men and became acutely infected with hepatitis C, the virus spontaneously cleared in nearly half the cases with higher percentages among men who were noninjection drug users than men who inject drugs, according to a prospective study out of Johns Hopkins University.

IBS patients are great, because many times they come to you frustrated they don't have a "diagnosis".

The probiotics didn't work well enough to cure patients, but the stool transplants miraculously did.

The guy microbiome is being studied across the healthcare spectrum as more is learned about this part of a person's anatomy. What it could mean for the treatment of multiple sclerosis has yet to be determined.

Pennies, chicken bones, and dishwasher cleaning powders. Gastroenterologists who work at hospitals are likely to get called in when people either accidentally or purposefully swallow something they should not. At the American College of Gastroenterology Annual Scientific Meeting in Honolulu, a physician at NYU Langone Medical Center offered a treatment primer.

All physicians want to deliver quality care. But do the checklists required to measure quality really add up to giving patients the results they want? As the American College of Gastroenterology Annual Scientific Meeting gets underway in Honolulu, the question came up in the context of managing irritable bowel disease.

Pancreatic cancer is hard to cure and even diagnosing it is challenging. Among the eagerly awaiting research topics to be presented at the American College of Gastroenterology Meeting in Honolulu, Hawaii are reports on new developments in detecting malignancies.

More than three-quarters of intravenous drug users and Baby Boomers tested for hepatitis C were positive and unaware they were infected, according to results of a study published in the journal Annals of Emergency Medicine.

Positive hepatitis C infection may increase risk for liver damage as well as future heart problems, according to findings published in The Journal of Infectious Diseases.

Just as overactive bladder issues and constipation are an issue for patients with multiple sclerosis, mirabegron is a popular medication in the general population for managing these issues. At the NYU Langone Medical Center Comprehensive Care Center patients receive treatment from a wide variety of healthcare professionals in order to get the best results possible for their condition.

Air pollution affects liver health and can cause fibrosis, according to findings published in the Journal of Hepatology.

Though it is still in development, a blood test may be able to detect pancreatic cancer in early stages, according to a proof of concept study published in Cancer Prevention Research.

Probiotics don't stop superbugs from colonizing in very ill patients' intestinal tracts, according to a recent study published in the journal Infection Control and Hospital Epidemiology.

Genetic mutations in hereditary colorectal cancers may be detectable, according to findings published in the Journal of Molecular Diagnostics.

Study results show there are minimal drug-drug interactions between tenofovir alafenamide-based antiretroviral regimens for HIV and ledipasvir/sofosbuvir combination treatment for hepatitis C.

A recent review article provided updated information on classification systems, preventive techniques, pathophysiological mechanisms, and treatment options for postoperative ileus.

A research team from Johns Hopkins Hospital in Baltimore, MD, set out to identify factors associated with variation in hospital hepatopancreatobiliary surgery charges.

Comparing current treatment models to lessons learned in the early days of the AIDs epidemic, University of Southern California researchers are advocating that more than just the sickest patients with hepatitis C be treated with new drugs that have much higher cure rates than past regimens.

The US Food and Drug Administration requested three manufacturers of duodenoscopes – Olympus America, Inc. Fujifilm Medical Systems, USA, Inc., and Hoya Corp – to perform real-world postmarket surveillance studies duodenoscopes used to perform endoscopic retrograde cholangiopancreatography procedures (ERCP).

Japanese regulators have approved AbbVie's Viekirax to treat patients with genotype 1 chronic hepatitis C, including those with compensated cirrhosis, the most common type of hepatitis in that country.

After much debate, waiting five years between colonoscopy procedures for low risk colorectal cancer (CRC) patients has recently been deemed acceptable by disease authorities.

Gilead continues a string of recent successes with stellar data from four late-stage studies showing that a combination featuring its blockbuster polymerase inhibitor sofosbuvir (Sovaldi®) and the experimental NS5A inhibitor velpatasvir is effective across all hepatitis C virus (HCV) genotypes.

A common liver health measurement could be a strong indicator of risk of hepatosteatosis in patients with chronic hepatitis C virus (HCV) infection, a Taiwanese study in BMJ Open suggests.

Researchers report high reinfection rates and attributable risk analysis suggest the existence of a subset of HIV-positive men who have sex with men with recurring sexual exposure to hepatitis C virus, which is troubling because HCV infections are more likely to become persistent and to lead to progressive liver disease in patients with HIV, including those on antiretroviral therapy.

As health officials take control of a Legionnaires' disease outbreak that has appeared in multiple cities throughout the US, which started in New York City, another potentially deadly bacteria has popped up on the radar.

Fixed-dose combination of velpatasvir and sofosbuvir produced high rates of 12-week sustained virologic response in patients with HCV genotypes 1 through 6.

Including dried plums as part of one's daily diet was found to potentially diminish the risk of colon cancer.